Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2023-02-03 Share Issue/Capital Cha…
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
BIOERA SPA - Comunicazione variazione capitale sociale depositato al Registro delle Imprese di Milano Monza Brianza Lodi
Share Issue/Capital Change Classification · 1% confidence The document is an official communication from BIOERA S.p.A. titled "Comunicazione di variazione del capitale sociale depositato al competente Registro delle Imprese di Milano-Monza-Brianza-Lodi" (Communication of change in share capital deposited with the competent Business Register of Milan-Monza-Brianza-Lodi). It details the issuance of new ordinary shares following the conversion of convertible bonds and provides the updated share capital structure and shareholder composition. This directly relates to changes in the company's capital structure and financing instruments (convertible bonds/warrants). Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-02-03 Italian
BIOERA SPA - Deposito documento informativo OPC
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement (2814 characters) from BIOERA SPA, dated February 2, 2023, titled "Deposito documento informativo relativo ad operazione di maggiore rilevanza con parti correlate" (Filing of information document relating to a major transaction with related parties). The key phrase is "Vedi allegato" (See attachment) and the text explicitly states that the "documento informativo (il 'Documento Informativo') è stato pubblicato" (the information document has been published) and is available on the company website and storage mechanism. According to Rule 2 (The 'Menu vs Meal' Rule), a short announcement stating that a report has been published or is attached should be classified as a Report Publication Announcement (RPA). The content relates to a specific disclosure document required for related-party transactions (OPC/Related Parties), but the document itself is merely the notice of publication.
2023-02-02 Italian
BIOERA SPA Documento Informativo OPC
Capital/Financing Update Classification · 1% confidence The document is titled "DOCUMENTO INFORMATIVO RELATIVO AD OPERAZIONE DI MAGGIORE RILEVANZA CON PARTE CORRELATA" (Informative Document Regarding a Related Party Transaction of Major Relevance). It explicitly references compliance with Italian regulatory body Consob's resolution (delibera n. 17221 del 12 marzo 2010) regarding related party transactions (Regolamento OPC). The content details the nature, terms, and economic rationale of a financing agreement and a private agreement involving related parties (Michele Mario Mazzaro and Canio Giovanni Mazzaro). This type of detailed disclosure concerning transactions with directors/major shareholders, mandated by specific securities regulations, aligns best with filings related to corporate governance, transactions, or specific regulatory disclosures. Given the focus on a significant transaction with related parties, it is a specific type of corporate disclosure. While it is not a standard US SEC filing like 10-K or DEF 14A, in the context of the provided definitions, it is a detailed report providing specific corporate/governance information related to a transaction. It is not a general earnings release (ER), an interim report (IR), or a simple announcement (RPA/RNS). The closest fit among the provided options, considering it details governance structure implications and specific related party dealings, is often categorized under governance or specific transaction disclosures. Since there isn't a specific 'Related Party Transaction Disclosure' code, and it heavily involves management/board members and their dealings, it relates closely to Governance Information (CGR) or potentially a specialized filing that falls under Regulatory Filings (RNS) if no better fit exists. However, given the depth and focus on the structure of the transaction and the parties involved, it is a specific corporate governance/transaction document. Since the document is substantial (35k chars) and is the report itself, not an announcement of a report, and deals with management/board involvement, I will classify it as Governance Information (CGR) as it details compliance with rules governing related party transactions, which is a core governance function, or potentially a specialized transaction disclosure. Given the options, and the focus on compliance with specific transaction rules involving directors, CGR is a strong candidate, but since it is a specific transaction disclosure, and not a general governance report, RNS (Regulatory Filings) serves as the best catch-all for specific, non-standard regulatory disclosures not covered elsewhere, especially for non-US specific filings. Re-evaluating: The document is a mandatory disclosure about a transaction involving related parties, which is a key aspect of corporate governance. CGR (Governance Information) is the most appropriate category for detailed reports on internal rules, board structure, and governance practices, which this document directly addresses by detailing compliance with related party transaction rules.
2023-02-02 Italian
BIOERA SPA Informativa al mercato ex art 114 TUF al 31 dicembre 2022
Management Reports Classification · 1% confidence The document is titled 'Informativa al mercato ai sensi dell'art. 114, comma 5, D.lgs. n. 58/98 ("TUF")' and reports financial data (net financial debt and overdue payables) as of December 31, 2022, comparing it to previous periods (Nov 30, 2022, and Dec 31, 2021). This structure, providing comprehensive financial updates for a specific period shorter than a full year (or a mandated update outside of the standard 10-K/10-Q cycle, often triggered by regulatory requests like the mentioned Art. 114 TUF), strongly indicates an Interim/Quarterly Report (IR). Although it is an update mandated by Consob, the content is a detailed financial status report, not just a brief announcement of publication (RPA) or a general regulatory filing (RNS). It is more detailed than a typical Earnings Release (ER) which usually contains only key highlights. Since it covers a period ending December 31st, it functions as a year-end or period-end financial disclosure, fitting the 'Interim / Quarterly Report' definition best, even if the reporting frequency is irregular due to regulatory mandate.
2023-01-31 Italian
BIOERA SPA Calendario Finanziario 2023
Report Publication Announcement Classification · 1% confidence The document is titled 'Calendario finanziario 2023' (Financial Calendar 2023) and lists specific future dates for key corporate events like board meetings for approving financial statements and the shareholder meeting for approval. It is an announcement detailing the schedule of future reports and meetings, rather than the reports themselves (like 10-K, IR, or ER). The document explicitly states 'Vedi allegato' (See attachment) and is short, suggesting it is an announcement about upcoming publications. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2023-01-30 Italian
BIOERA SPA - Operazioni con parti correlate - proroga termine scadenza rimborso Debenture Note 2018-2021
Capital/Financing Update Classification · 1% confidence The document is a formal press release ('COMUNICATO STAMPA') from BIOERA S.p.A. dated January 26, 2023, detailing specific financial transactions involving related parties ('Operazioni con parti correlate'). These transactions include granting a loan ('Finanziamento') and an agreement regarding the repayment of existing debt ('Debenture Note 2018-2021'). The text explicitly mentions compliance with Italian regulations regarding related party transactions (Procedura OPC, TUF, Regolamento Consob Parti Correlate) and the requirement to prepare an 'Documento Informativo' (Informative Document) for the market. This content strongly relates to corporate financing, capital structure management, and mandatory disclosures concerning related parties, which falls under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS) if it were a general announcement. However, since the core subject is the approval and execution of specific financing arrangements and debt restructuring involving related parties, 'CAP' (Capital/Financing Update) is the most specific fit, as it covers fundraising and capital structure changes, even when disclosed via related party rules. It is not a general earnings release (ER), an annual report (10-K), or a simple dividend notice (DIV). Given the focus on securing funds and managing debt obligations, CAP is appropriate.
2023-01-26 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.